Valhalla, N.Y. - A new study, led by two researchers from New York Medical College, Mitchell S. Cairo, M.D., professor of pediatrics, division of pediatric hematology, oncology and stem cell transplantation, and professor of medicine, pathology, microbiology and immunology, and cell biology and anatomy and vice chairman of the Department of Pediatrics at New York Medical College and Yanling Liao, Ph.D., clinical assistant professor of pediatrics, suggests that stem cells could be the key to treating symptoms of RDEB—the genetic condition characterized by extremely fragile skin.